166 related articles for article (PubMed ID: 28749655)
1. Cyclometalated Iridium(III)-Complex-Based Micelles for Glutathione-Responsive Targeted Chemotherapy and Photodynamic Therapy.
Xiang H; Chen H; Tham HP; Phua SZF; Liu JG; Zhao Y
ACS Appl Mater Interfaces; 2017 Aug; 9(33):27553-27562. PubMed ID: 28749655
[TBL] [Abstract][Full Text] [Related]
2. Cyclometalated Ir(III) theranostic molecular probe enabled mitochondria targeted fluorescence-SERS-guided phototherapy in breast cancer cells.
Reghukumar C; Shamjith S; Murali VP; Ramya PK; Radhakrishnan KV; Maiti KK
J Photochem Photobiol B; 2024 Jan; 250():112832. PubMed ID: 38142588
[TBL] [Abstract][Full Text] [Related]
3. Rational Design of Phosphorescent Iridium(III) Complexes for Selective Glutathione Sensing and Amplified Photodynamic Therapy.
Huang T; Yu Q; Liu S; Zhang KY; Huang W; Zhao Q
Chembiochem; 2019 Feb; 20(4):576-586. PubMed ID: 30267457
[TBL] [Abstract][Full Text] [Related]
4. Exploring a Mitochondria Targeting, Dinuclear Cyclometalated Iridium (III) Complex for Image-Guided Photodynamic Therapy in Triple-Negative Breast Cancer Cells.
Neelambaran N; Shamjith S; Murali VP; Maiti KK; Joseph J
ACS Appl Bio Mater; 2023 Dec; 6(12):5776-5788. PubMed ID: 38061031
[TBL] [Abstract][Full Text] [Related]
5. Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.
Zheng Y; He L; Zhang DY; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11395-11407. PubMed ID: 28813052
[TBL] [Abstract][Full Text] [Related]
6. Amphiphilic Gemini Iridium(III) Complex as a Mitochondria-Targeted Theranostic Agent for Tumor Imaging and Photodynamic Therapy.
Yi S; Lu Z; Zhang J; Wang J; Xie Z; Hou L
ACS Appl Mater Interfaces; 2019 May; 11(17):15276-15289. PubMed ID: 30968687
[TBL] [Abstract][Full Text] [Related]
7. Intracellular GSH-activated galactoside photosensitizers for targeted photodynamic therapy and chemotherapy.
Wang C; Liu L; Cao H; Zhang W
Biomater Sci; 2017 Jan; 5(2):274-284. PubMed ID: 27942618
[TBL] [Abstract][Full Text] [Related]
8. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW
Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019
[TBL] [Abstract][Full Text] [Related]
9. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
10. Cyclometalated iridium(iii) complex nanoparticles for mitochondria-targeted photodynamic therapy.
Lu H; Jiang X; Chen Y; Peng K; Huang Y; Zhao H; Chen Q; Lv F; Liu L; Wang S; Ma Y
Nanoscale; 2020 Jul; 12(26):14061-14067. PubMed ID: 32582896
[TBL] [Abstract][Full Text] [Related]
11. Two near-infrared phosphorescent iridium(III) complexes for the detection of GSH and photodynamic therapy.
Tu R; Liu J; Chen W; Fu F; Li MJ
Dalton Trans; 2023 Sep; 52(37):13137-13145. PubMed ID: 37655695
[TBL] [Abstract][Full Text] [Related]
12. A Cyclometalated Ir
Sudheesh KV; Jayaram PS; Samanta A; Bejoymohandas KS; Jayasree RS; Ajayaghosh A
Chemistry; 2018 Aug; 24(43):10999-11007. PubMed ID: 29806867
[TBL] [Abstract][Full Text] [Related]
13. Cyclometalated iridium(iii) complexes as lysosome-targeted photodynamic anticancer and real-time tracking agents.
He L; Li Y; Tan CP; Ye RR; Chen MH; Cao JJ; Ji LN; Mao ZW
Chem Sci; 2015 Oct; 6(10):5409-5418. PubMed ID: 29861886
[TBL] [Abstract][Full Text] [Related]
14. Development of Wireless Power-Transmission-Based Photodynamic Therapy for the Induction of Cell Death in Cancer Cells by Cyclometalated Iridium(III) Complexes.
Yokoi K; Yasuda Y; Kanbe A; Imura T; Aoki S
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771099
[TBL] [Abstract][Full Text] [Related]
15. A new near-infrared phosphorescent iridium(III) complex conjugated to a xanthene dye for mitochondria-targeted photodynamic therapy.
Wu Y; Wu J; Wong WY
Biomater Sci; 2021 Jul; 9(14):4843-4853. PubMed ID: 33998610
[TBL] [Abstract][Full Text] [Related]
16. Hydrogen Sulfide-Induced Activatable Photodynamic Therapy Adjunct to Disruption of Subcellular Glycolysis in Cancer Cells by a Fluorescence-SERS Bimodal Iridium Metal-Organic Hybrid.
Shamjith S; Murali VP; Joesph MM; T S F; Chandana R; Jayarajan RO; Maiti KK
ACS Appl Mater Interfaces; 2024 May; 16(21):27114-27126. PubMed ID: 38747624
[TBL] [Abstract][Full Text] [Related]
17. Dual Functions of Cyclometalated Iridium(III) Complexes: Anti-Metastasis and Lysosome-Damaged Photodynamic Therapy.
Wang FX; Chen MH; Lin YN; Zhang H; Tan CP; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2017 Dec; 9(49):42471-42481. PubMed ID: 29140069
[TBL] [Abstract][Full Text] [Related]
18. Towards Novel Photodynamic Anticancer Agents Generating Superoxide Anion Radicals: A Cyclometalated Ir
Novohradsky V; Rovira A; Hally C; Galindo A; Vigueras G; Gandioso A; Svitelova M; Bresolí-Obach R; Kostrhunova H; Markova L; Kasparkova J; Nonell S; Ruiz J; Brabec V; Marchán V
Angew Chem Int Ed Engl; 2019 May; 58(19):6311-6315. PubMed ID: 30889300
[TBL] [Abstract][Full Text] [Related]
19. Enhanced photodynamic efficiency achieved via a dual-targeted strategy based on photosensitizer/micelle structure.
Xu J; Zeng F; Wu H; Hu C; Wu S
Biomacromolecules; 2014 Nov; 15(11):4249-59. PubMed ID: 25329523
[TBL] [Abstract][Full Text] [Related]
20. Phosphorescent iridium(III)-bis-N-heterocyclic carbene complexes as mitochondria-targeted theranostic and photodynamic anticancer agents.
Li Y; Tan CP; Zhang W; He L; Ji LN; Mao ZW
Biomaterials; 2015 Jan; 39():95-104. PubMed ID: 25477176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
